Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Empagliflozin in Patients With Hypertrophic Cardiomyopathy

NCT05182658 is registered in ClinicalTrials.gov with National Institute of Cardiology, Warsaw, Poland as lead sponsor.

NCT NCT05182658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05182658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Empagliflozin in Patients With Hypertrophic Cardiomyopathy
Lead sponsor
National Institute of Cardiology, Warsaw, Poland
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 1, 2022
Completion date
November 30, 2026
Enrollment
250 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, hypertrophic cardiomyopathy